Organization Profile

You just read:

Pivotal Therapeutics Announces Notification of Patent Allowance for U.S. Application 13/584,480 Related to Combination Product of VASCAZEN® and Statin Therapy

News provided by

Pivotal Therapeutics Inc.

Oct 07, 2014, 07:00 ET